217 Results for "

first-in-class

" in MedChemExpress (MCE) Product Catalog:
Products (217)

217 Results for "first-in-class" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-109108A
CAS No.: 1809336-93-3
Purity:  99.84%
Synonyms: DS-3201 tosylate
Research Areas:  

Cancer

Valemetostat (DS-3201) tosylate, a first-in-class EZH1/2 dual inhibitor with IC50 values <10 nM. Valemetostat tosylate can be used for the research of relapsed/refractory peripheral T-cell lymphoma .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-112233
CAS No.: 1261289-04-6
Purity:  99.50%
Target:  

AMPK

O-304 is a first-in-class, orally available pan-AMPK activator, which increases AMPK activity by suppressing the dephosphorylation of pAMPK. O-304 exhibits a great potential as a agent to treat type 2 diabetes (T2D) and associated cardiovascular complications .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-136259
CAS No.: 1417700-13-0
Purity:  99.87%
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

ML188, a first in class probe, is a selective non-covalent SARS-CoV 3CLpro inhibitor with an IC50 of 1.5 μM. Antiviral activity .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-110273
CAS No.: 862974-25-2
Purity:  99.58%
Research Areas:  

Cardiovascular Disease

N106 is a first-in-class sarcoplasmic reticulum calcium ATPase (SERCA2a) SUMOylation activator. N106 directly activates the SUMO-activating enzyme, E1 ligase. N106 can be used for heart failure research .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-12820
CAS No.: 1616113-45-1
Purity:  99.70%
Synonyms: Antibiotic-202
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

Sibofimloc (Antibiotic-202) is a first-in-class, gut-restricted, orally active FimH adhesion inhibitor extracted from patent WO2014100158A1, Compound Example 202. Sibofimloc has anti-bacterial infective activity. Sibofimloc is developed for inflammatory bowel disease (IBD) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-128357
CAS No.: 1275582-97-2
Purity:  ≥98.0%
Synonyms: ACX-362E; GLS-362E
Research Areas:  

Infection

Ibezapolstat (ACX-362E) is a first-in-class, orally active DNA polymerase IIIC (pol IIIC) inhibitor, with a Ki of 0.325 μM for the DNA pol IIIC from C. difficile. Ibezapolstat is developed for the research of C. difficile infection(CDI) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-114419
CAS No.: 1629677-75-3
Purity:  99.89%
Synonyms: KZR-616
Target:  

Proteasome

Research Areas:  

Inflammation/Immunology

Zetomipzomib (KZR-616), a first-in-class inhibitor of the immunoproteasome, selectively targets the LMP7 (IC50: 39/57 nM=hLMP7/mLMP7) and LMP2 (IC50: 131/179 nM=hLMP7/mLMP7) subunits of the immunoproteasome. Zetomipzomib has the potential for the research of multiple autoimmune diseases .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-114419A
CAS No.: 2170983-62-5
Purity:  99.84%
Synonyms: KZR-616 maleate
Target:  

Proteasome

Research Areas:  

Inflammation/Immunology

Zetomipzomib (KZR-616) maleate, a first-in-class immunoproteasome inhibitor, selectively targets the LMP7 (IC50: 39/57 nM=hLMP7/mLMP7) and LMP2 (IC50: 131/179 nM=hLMP2/mLMP2) subunits of the immunoproteasome. Zetomipzomib maleate has the potential for the research of multiple autoimmune diseases .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-123981
CAS No.: 47208-82-2
Purity:  99.72%
Target:  

Phosphatase

Research Areas:  

Cancer

5MPN is a first-in-class, potent, orally active and selective 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) inhibitor. 5MPN appears to be a competitive inhibitor of the F6P binding site (Ki=8.6 μM). 5MPN does not inhibit PFK-1 or PFKFB3. 5MPN targets the sugar metabolism of tumors and suppresses proliferation of multiple human cancer cell lines .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-10534
CAS No.: 175414-77-4
Purity:  99.26%
Synonyms: SNS-595; Vosaroxin; AG 7352
Target:  

Topoisomerase Apoptosis

Research Areas:  

Cancer

Voreloxin (SNS-595; Vosaroxin; AG 7352) is a first-in-class topoisomerase II inhibitor that intercalates DNA and induces site-selective DNA DSB, G2 arrest, and apoptosis.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-131181
CAS No.: 2393840-15-6
Purity:  99.73%
Target:  

Phospholipase

Research Areas:  

Neurological Disease

LEI-401 is a first-in-class, selective, and CNS-active NAPE-PLD (N-acylphosphatidylethanolamine phospholipase D) inhibitor, with an IC50 of 27 nM. LEI-401 modulates emotional behavior in mice .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-124600
CAS No.: 1445790-55-5
Purity:  99.88%
Target:  

HBV

Research Areas:  

Infection

NVR 3-778 is a first-in-Class and oral bioavailable HBV CAM (capsid assembly modulator) belonging to the SBA (sulfamoylbenzamide) class, with anti-HBV activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16518
CAS No.: 175519-16-1
Synonyms: SNS-595 Hydrochloride; Vosaroxin Hydrochloride; AG 7352 Hydrochloride
Target:  

Topoisomerase Apoptosis

Research Areas:  

Cancer

Voreloxin Hydrochloride is a first-in-class topoisomerase II inhibitor that intercalates DNA and induces site-selective DNA DSB, G2 arrest, and apoptosis.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-107390
CAS No.: 1370544-73-2
Purity:  99.29%
AX-024 is an orally available, first-in-class inhibitor of the TCR-Nck interaction that selectively inhibits TCR-triggered T cell activation with an IC50 ~1 nM. AX-024 modulates cell signaling by targeting SH3 domains. AX-024 has low-acute toxicity and high potency and selectivity, and strongly inhibit the production of IL-6, TNF-α, IFN-γ, IL-10 and IL-17A.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-107390A
CAS No.: 1704801-24-0
Purity:  99.75%
AX-024 hydrochloride is an orally available, first-in-class inhibitor of the TCR-Nck interaction that selectively inhibits TCR-triggered T cell activation with an IC50 ~1 nM. AX-024 hydrochloride modulates cell signaling by targeting SH3 domains. AX-024 hydrochloride has low-acute toxicity and high potency and selectivity, and strongly inhibit the production of IL-6, TNF-α, IFN-γ, IL-10 and IL-17A.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-101925
CAS No.: 1846570-31-7
Purity:  98.70%
CM-272 is a first-in-class, potent, selective, substrate-competitive and reversible dual G9a/DNA methyltransferases (DNMTs) inhibitor with antitumor activities. CM-272 inhibits G9a, DNMT1, DNMT3A, DNMT3B and GLP with IC50s of 8 nM, 382 nM, 85 nM, 1200 nM and 2 nM, respectively. CM-272 inhibits cell proliferation and promotes apoptosis, inducing IFN-stimulated genes and immunogenic cell death .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P99575
CAS No.: 2307488-83-9
Synonyms: AMG-757

Target:  

Notch

Research Areas:  

Inflammation/Immunology Cancer

Tarlatamab (AMG-757) is a bispecific T-cell engager (BiTE) antibody targeting delta-like ligand 3 (DLL3). DLL3 is a target that is selectively expressed in small-cell lung cancer (SCLC) tumors, but with minimal normal tissue expression. Tarlatamab has the KDs of 0.64 nM and 0.50 nM for human and nonhuman primate (NHP) DLL3, respectively. Tarlatamab has the KDs of 14.9 nM and 12 nM for human and NHP CD3, respectively. Tarlatamab is a first-in-class HLE BiTE immuno-oncology therapy targeting DLL3 and has the potential for SCLC research .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-122913
CAS No.: 1800070-77-2
Purity:  99.18%
Target:  

Akt

Research Areas:  

Cancer

Borussertib, a chemical probe, is a covalent-allosteric and first-in-class inhibitor of protein kinase Akt, with an IC50 of 0.8 nM and a Ki of 2.2 nM for Akt wt .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-139399
CAS No.: 2230273-76-2
Purity:  99.63%
Synonyms: JNJ-67856633
Target:  

MALT1

Research Areas:  

Cancer

Safimaltib (JNJ-67856633) is an orally active, first-in-class, potent, selective and allosteric MALT1 protease inhibitor. Safimaltib in some cases lead to tumor stasis .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-12814
CAS No.: 1609960-31-7
Purity:  99.20%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

TH588 is first-in-class nudix hydrolase family inhibitor that potently and selectively engage and inhibit the MTH1 (IC50= 5 nM).
loading...
    loading...